Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Julia L Fleck"'
Autor:
Julia L Fleck, Daniëlle Hooijenga, Raksmey Phan, Xiaolan Xie, Vincent Augusto, Pierre-Etienne Heudel
Publikováno v:
PLoS ONE, Vol 18, Iss 8, p e0290566 (2023)
Guidelines for the management of elderly patients with early breast cancer are scarce. Additional adjuvant systemic treatment to surgery for early breast cancer in elderly populations is challenged by increasing comorbidities with age. In non-metasta
Externí odkaz:
https://doaj.org/article/668a6a15627f426f9705883176573fb5
Publikováno v:
PLoS ONE, Vol 16, Iss 9, p e0238757 (2021)
Cancer cell lines, which are cell cultures derived from tumor samples, represent one of the least expensive and most studied preclinical models for drug development. Accurately predicting drug responses for a given cell line based on molecular featur
Externí odkaz:
https://doaj.org/article/cda66912ff464280b536bf53c158d2e1
Autor:
Salomón Wollenstein-Betech, Amanda A B Silva, Julia L Fleck, Christos G Cassandras, Ioannis Ch Paschalidis
Publikováno v:
PLoS ONE, Vol 15, Iss 10, p e0240346 (2020)
BackgroundGiven the severity and scope of the current COVID-19 pandemic, it is critical to determine predictive features of COVID-19 mortality and medical resource usage to effectively inform health, risk-based physical distancing, and work accommoda
Externí odkaz:
https://doaj.org/article/d07e0098a46240f2b1d63f6c837d711e
Autor:
Lucas Becker, Felix Fischer, Julia L. Fleck, Niklas Harland, Alois Herkommer, Arnulf Stenzl, Wilhelm K. Aicher, Katja Schenke-Layland, Julia Marzi
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 13, p 6956 (2022)
Three-dimensional (3D) organoid culture recapitulating patient-specific histopathological and molecular diversity offers great promise for precision medicine in cancer. In this study, we established label-free imaging procedures, including Raman micr
Externí odkaz:
https://doaj.org/article/be39d9c76bb54bdfa26b19a98435aa3b
Publikováno v:
IFAC-PapersOnLine. 53:478-484
In this paper, we propose a stochastic programming approach to perform optimal and robust offshore flight scheduling from a service level perspective, reducing flight delays. The two-stage stochastic programming is reduced to a deterministic equivale
Publikováno v:
European Journal of Operational Research. 273:831-840
Among the many challenges involved in efficient healthcare resource planning, the Patient Admission Scheduling Problem is of particular significance, impacting organizational decisions at all planning levels. The problem of scheduling patient admissi
Publikováno v:
PLoS ONE, Vol 16, Iss 9, p e0238757 (2021)
PLoS ONE
PLoS ONE
Cancer cell lines, which are cell cultures derived from tumor samples, represent one of the least expensive and most studied preclinical models for drug development. Accurately predicting drug responses for a given cell line based on molecular featur
Autor:
Stephen R. Piccolo, Paula Medina Maçaira, Julia L. Fleck, Sofia Pontes de Miranda, Fernanda Araujo Baião
Cancer cell lines, which are cell cultures developed from tumor samples, represent one of the least expensive and most studied preclinical models for drug development. Accurately predicting drug response for a given cell line based on molecular featu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::78282a261509128bf7f6b6ba0fff3418
https://doi.org/10.1101/2020.08.25.266049
https://doi.org/10.1101/2020.08.25.266049
Autor:
Julia L. Fleck, Ioannis Ch. Paschalidis, Amanda de Araújo Batista da Silva, Christos G. Cassandras, Salomón Wollenstein-Betech
Publikováno v:
PLoS ONE, Vol 15, Iss 10, p e0240346 (2020)
PLoS ONE
PLoS ONE
BackgroundGiven the severity and scope of the current COVID-19 pandemic, it is critical to determine predictive features of COVID-19 mortality and medical resource usage to effectively inform health, risk-based physical distancing, and work accommoda
Autor:
Julia L. Fleck, Christos G. Cassandras
Publikováno v:
Nonlinear Analysis: Hybrid Systems. 25:246-262
The standard treatment for advanced prostate cancer is hormone therapy in the form of continuous androgen suppression (CAS), which unfortunately frequently leads to resistance and relapse. An alternative scheme is intermittent androgen suppression (I